The use of plasma rich in growth factors (PRGF-Endoret) in the treatment of a severe mal perforant ulcer in the foot of a person with diabetes

Beatriz Orcajo; Francisco Muruzabal; María Concepción Isasmendi; Nerea Gutierrez; Mikel Sánchez; Gorka Orive; Eduardo Anitua

doi:10.1016/j.diabres.2011.04.008

The use of plasma rich in growth factors (PRGF-Endoret) in the treatment of a severe mal perforant ulcer in the foot of a person with diabetes

Diabetes Res Clin Pract. 2011 Aug;93(2):e65-e67. doi: 10.1016/j.diabres.2011.04.008. Epub 2011 May 5.

Authors

Beatriz Orcajo¹, Francisco Muruzabal², María Concepción Isasmendi³, Nerea Gutierrez³, Mikel Sánchez⁴, Gorka Orive², Eduardo Anitua²

Affiliations

¹ Clinica Juber, Plaza San Antón 4, 01002 Vitoria, Spain. Electronic address: clinicajuber@gmail.com.
² Instituto Eduardo Anitua, c/Jose Maria Cajigal 19, 10005 Vitoria, Spain.
³ Clinica Juber, Plaza San Antón 4, 01002 Vitoria, Spain.
⁴ Unidad de Cirugía Artroscópica "Mikel Sánchez", c/La Esperanza, 01005 Vitoria, Spain.

PMID: 21546112
DOI: 10.1016/j.diabres.2011.04.008

Abstract

A 71 year old person with diabetes with a severe mal perforant ulcer in the right foot was treated twice with autologous plasma-rich in growth factors (PRGF) obtained from her own blood. After PRGF treatment the severe mal perforant ulcer completely healed in 10 weeks.

Publication types

Case Reports

MeSH terms

Aged
Diabetes Mellitus / drug therapy
Diabetic Angiopathies
Diabetic Foot / drug therapy*
Female
Humans
Intercellular Signaling Peptides and Proteins / therapeutic use*
Plasma
Wound Healing / drug effects

Substances

Intercellular Signaling Peptides and Proteins